Assessment and Diagnosis of HIV-Associated Dementia
HIV infection has long been known to result in dementia and other forms of neurocognitive deficits. The rate of HIV-associated dementia is decreasing, while mild forms of neurological impairments increase. Treatment of HIV infection has advanced, and patients are living longer, and are thus at a gre...
Gespeichert in:
| Veröffentlicht in: | Journal for nurse practitioners 2018-03, Vol.14 (3), p.190-195 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 195 |
|---|---|
| container_issue | 3 |
| container_start_page | 190 |
| container_title | Journal for nurse practitioners |
| container_volume | 14 |
| creator | Kimani, Rachel W. |
| description | HIV infection has long been known to result in dementia and other forms of neurocognitive deficits. The rate of HIV-associated dementia is decreasing, while mild forms of neurological impairments increase. Treatment of HIV infection has advanced, and patients are living longer, and are thus at a greater risk of cognitive decline. The HIV aging cohort is susceptible to neurocognitive impairment from other medical conditions that have a compounding effect on cognitive decline. The diagnosis of HIV-associated neurocognitive disorders involves identifying neurological dysfunction and then determining that HIV is the most probable cause. Implications for practice include early control of HIV replication and treatment of comorbid diseases.
•HIV associated neurocognitive disorder (HAND) affects patients’ quality of life.•HIV-related dementia is decreasing, while mild HAND increases.•cART has increased survival of PLWH, thus at a greater risk of cognitive decline.•Treatment of HIV of comorbid disease can decrease risk of cognitive impairment.•Hepatitis C treatment should be offered absent of contraindications. |
| doi_str_mv | 10.1016/j.nurpra.2017.12.031 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2012401762</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1555415518300412</els_id><sourcerecordid>2012401762</sourcerecordid><originalsourceid>FETCH-LOGICAL-c334t-deb4e758da49b2739404e6ed3e3221b2b595bd214573e23865301c7180c957f43</originalsourceid><addsrcrecordid>eNp9UE1LxDAQDaLguvoPPBQ8t-azaS_Csn7swoIXFW8hTaaS4jY1aQX_vSn17GVm4L03M-8hdE1wQTApb7uin8IQdEExkQWhBWbkBK1IJasci-r9NM1CiJyneo4uYuwwZlXJ-AqxTYwQ4xH6MdO9ze6d_uh9dDHzbbbbv-UJ98bpERIGM83pS3TW6s8IV399jV4fH162u_zw_LTfbg65YYyPuYWGgxSV1bxuqGQ1xxxKsAwYpaShjahFYynhQjKg6R_BMDGSVNjUQracrdHNsncI_muCOKrOT6FPJ1UySnkyW9LE4gvLBB9jgFYNwR11-FEEqzke1aklnlklFaEqxZNkd4sMkoNvB0FF46A3YF0AMyrr3f8LfgG9Km2r</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2012401762</pqid></control><display><type>article</type><title>Assessment and Diagnosis of HIV-Associated Dementia</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Elsevier ScienceDirect Journals</source><creator>Kimani, Rachel W.</creator><creatorcontrib>Kimani, Rachel W.</creatorcontrib><description>HIV infection has long been known to result in dementia and other forms of neurocognitive deficits. The rate of HIV-associated dementia is decreasing, while mild forms of neurological impairments increase. Treatment of HIV infection has advanced, and patients are living longer, and are thus at a greater risk of cognitive decline. The HIV aging cohort is susceptible to neurocognitive impairment from other medical conditions that have a compounding effect on cognitive decline. The diagnosis of HIV-associated neurocognitive disorders involves identifying neurological dysfunction and then determining that HIV is the most probable cause. Implications for practice include early control of HIV replication and treatment of comorbid diseases.
•HIV associated neurocognitive disorder (HAND) affects patients’ quality of life.•HIV-related dementia is decreasing, while mild HAND increases.•cART has increased survival of PLWH, thus at a greater risk of cognitive decline.•Treatment of HIV of comorbid disease can decrease risk of cognitive impairment.•Hepatitis C treatment should be offered absent of contraindications.</description><identifier>ISSN: 1555-4155</identifier><identifier>EISSN: 1878-058X</identifier><identifier>DOI: 10.1016/j.nurpra.2017.12.031</identifier><language>eng</language><publisher>Philadelphia: Elsevier Inc</publisher><subject>Acquired immune deficiency syndrome ; Aging ; AIDS ; AIDS dementia complex ; Antiretroviral drugs ; Cognitive impairment ; combined antiretrovirals (cART) ; Comorbidity ; Dementia ; Hepatitis ; hepatitis C ; HIV ; HIV treatment ; HIV-associated neurocognitive disorder (HAND) ; HIV-dementia (HAD) ; Human immunodeficiency virus ; Infections ; Medical conditions ; Medical diagnosis ; Neurocognition ; Patient assessment ; Risk assessment</subject><ispartof>Journal for nurse practitioners, 2018-03, Vol.14 (3), p.190-195</ispartof><rights>2018 Elsevier Inc.</rights><rights>Copyright Elsevier Limited Mar 1, 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c334t-deb4e758da49b2739404e6ed3e3221b2b595bd214573e23865301c7180c957f43</citedby><cites>FETCH-LOGICAL-c334t-deb4e758da49b2739404e6ed3e3221b2b595bd214573e23865301c7180c957f43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1555415518300412$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,12825,27901,27902,30976,65306</link.rule.ids></links><search><creatorcontrib>Kimani, Rachel W.</creatorcontrib><title>Assessment and Diagnosis of HIV-Associated Dementia</title><title>Journal for nurse practitioners</title><description>HIV infection has long been known to result in dementia and other forms of neurocognitive deficits. The rate of HIV-associated dementia is decreasing, while mild forms of neurological impairments increase. Treatment of HIV infection has advanced, and patients are living longer, and are thus at a greater risk of cognitive decline. The HIV aging cohort is susceptible to neurocognitive impairment from other medical conditions that have a compounding effect on cognitive decline. The diagnosis of HIV-associated neurocognitive disorders involves identifying neurological dysfunction and then determining that HIV is the most probable cause. Implications for practice include early control of HIV replication and treatment of comorbid diseases.
•HIV associated neurocognitive disorder (HAND) affects patients’ quality of life.•HIV-related dementia is decreasing, while mild HAND increases.•cART has increased survival of PLWH, thus at a greater risk of cognitive decline.•Treatment of HIV of comorbid disease can decrease risk of cognitive impairment.•Hepatitis C treatment should be offered absent of contraindications.</description><subject>Acquired immune deficiency syndrome</subject><subject>Aging</subject><subject>AIDS</subject><subject>AIDS dementia complex</subject><subject>Antiretroviral drugs</subject><subject>Cognitive impairment</subject><subject>combined antiretrovirals (cART)</subject><subject>Comorbidity</subject><subject>Dementia</subject><subject>Hepatitis</subject><subject>hepatitis C</subject><subject>HIV</subject><subject>HIV treatment</subject><subject>HIV-associated neurocognitive disorder (HAND)</subject><subject>HIV-dementia (HAD)</subject><subject>Human immunodeficiency virus</subject><subject>Infections</subject><subject>Medical conditions</subject><subject>Medical diagnosis</subject><subject>Neurocognition</subject><subject>Patient assessment</subject><subject>Risk assessment</subject><issn>1555-4155</issn><issn>1878-058X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><sourceid>BENPR</sourceid><recordid>eNp9UE1LxDAQDaLguvoPPBQ8t-azaS_Csn7swoIXFW8hTaaS4jY1aQX_vSn17GVm4L03M-8hdE1wQTApb7uin8IQdEExkQWhBWbkBK1IJasci-r9NM1CiJyneo4uYuwwZlXJ-AqxTYwQ4xH6MdO9ze6d_uh9dDHzbbbbv-UJ98bpERIGM83pS3TW6s8IV399jV4fH162u_zw_LTfbg65YYyPuYWGgxSV1bxuqGQ1xxxKsAwYpaShjahFYynhQjKg6R_BMDGSVNjUQracrdHNsncI_muCOKrOT6FPJ1UySnkyW9LE4gvLBB9jgFYNwR11-FEEqzke1aklnlklFaEqxZNkd4sMkoNvB0FF46A3YF0AMyrr3f8LfgG9Km2r</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Kimani, Rachel W.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>ASE</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>HEHIP</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>201803</creationdate><title>Assessment and Diagnosis of HIV-Associated Dementia</title><author>Kimani, Rachel W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c334t-deb4e758da49b2739404e6ed3e3221b2b595bd214573e23865301c7180c957f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Aging</topic><topic>AIDS</topic><topic>AIDS dementia complex</topic><topic>Antiretroviral drugs</topic><topic>Cognitive impairment</topic><topic>combined antiretrovirals (cART)</topic><topic>Comorbidity</topic><topic>Dementia</topic><topic>Hepatitis</topic><topic>hepatitis C</topic><topic>HIV</topic><topic>HIV treatment</topic><topic>HIV-associated neurocognitive disorder (HAND)</topic><topic>HIV-dementia (HAD)</topic><topic>Human immunodeficiency virus</topic><topic>Infections</topic><topic>Medical conditions</topic><topic>Medical diagnosis</topic><topic>Neurocognition</topic><topic>Patient assessment</topic><topic>Risk assessment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kimani, Rachel W.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Sociology Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Sociology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Journal for nurse practitioners</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kimani, Rachel W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment and Diagnosis of HIV-Associated Dementia</atitle><jtitle>Journal for nurse practitioners</jtitle><date>2018-03</date><risdate>2018</risdate><volume>14</volume><issue>3</issue><spage>190</spage><epage>195</epage><pages>190-195</pages><issn>1555-4155</issn><eissn>1878-058X</eissn><abstract>HIV infection has long been known to result in dementia and other forms of neurocognitive deficits. The rate of HIV-associated dementia is decreasing, while mild forms of neurological impairments increase. Treatment of HIV infection has advanced, and patients are living longer, and are thus at a greater risk of cognitive decline. The HIV aging cohort is susceptible to neurocognitive impairment from other medical conditions that have a compounding effect on cognitive decline. The diagnosis of HIV-associated neurocognitive disorders involves identifying neurological dysfunction and then determining that HIV is the most probable cause. Implications for practice include early control of HIV replication and treatment of comorbid diseases.
•HIV associated neurocognitive disorder (HAND) affects patients’ quality of life.•HIV-related dementia is decreasing, while mild HAND increases.•cART has increased survival of PLWH, thus at a greater risk of cognitive decline.•Treatment of HIV of comorbid disease can decrease risk of cognitive impairment.•Hepatitis C treatment should be offered absent of contraindications.</abstract><cop>Philadelphia</cop><pub>Elsevier Inc</pub><doi>10.1016/j.nurpra.2017.12.031</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1555-4155 |
| ispartof | Journal for nurse practitioners, 2018-03, Vol.14 (3), p.190-195 |
| issn | 1555-4155 1878-058X |
| language | eng |
| recordid | cdi_proquest_journals_2012401762 |
| source | Applied Social Sciences Index & Abstracts (ASSIA); Elsevier ScienceDirect Journals |
| subjects | Acquired immune deficiency syndrome Aging AIDS AIDS dementia complex Antiretroviral drugs Cognitive impairment combined antiretrovirals (cART) Comorbidity Dementia Hepatitis hepatitis C HIV HIV treatment HIV-associated neurocognitive disorder (HAND) HIV-dementia (HAD) Human immunodeficiency virus Infections Medical conditions Medical diagnosis Neurocognition Patient assessment Risk assessment |
| title | Assessment and Diagnosis of HIV-Associated Dementia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T21%3A37%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20and%20Diagnosis%20of%20HIV-Associated%20Dementia&rft.jtitle=Journal%20for%20nurse%20practitioners&rft.au=Kimani,%20Rachel%20W.&rft.date=2018-03&rft.volume=14&rft.issue=3&rft.spage=190&rft.epage=195&rft.pages=190-195&rft.issn=1555-4155&rft.eissn=1878-058X&rft_id=info:doi/10.1016/j.nurpra.2017.12.031&rft_dat=%3Cproquest_cross%3E2012401762%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2012401762&rft_id=info:pmid/&rft_els_id=S1555415518300412&rfr_iscdi=true |